Back to search

United Kingdom· GB-APID-10191811000001104

Boots Soothing eye drops

A medicinal product containing hamamelis + cetrimide, registered in United Kingdom by The Boots Company Plc.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBoots Soothing eye dropsATC—REGISTER NO.GB-APID-1019181100000…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Hamamelis + Cetrimide
Manufacturer
The Boots Company Plc
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/09464811-f10a-4a9e-8d1d-87267540803e
GET /v1/drugs/09464811-f10a-4a9e-8d1d-87267540803e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "10191811000001104",
  "desc": "Boots Soothing eye drops (The Boots Company Plc)",
  "form": "Eye drops",
  "vpid": "10196811000001109",
  "source": "dmd",
  "vtm_id": "775145000",
  "strength": "100 microgram",
  "substance": "Hamamelis + Cetrimide",
  "ingredient": "Cetrimide",
  "supplier_code": "7497111000001106"
}

See everything about hamamelis + cetrimide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.